Form 4 for EXEL EXELIXIS, INC.

Accepted 2022-01-06 00:00:00 ET · period of report 2022-01-04 · accession 0000939767-22-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2022-01-06	2022-01-04	EXEL	Goodman Vicki L	EVP, CMO, Prod Dev, Med Aff	A - Grant	$0.00	+250.0K	250.0K	New	$0
	2022-01-06	2022-01-04	EXEL	Goodman Vicki L	EVP, CMO, Prod Dev, Med Aff	F - Tax	$19.18	-7,613	242.4K	-3%	-$146.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-01-04	A	A	250,000	$0.00	250,000	D	—	—	(F1) Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. (F2) The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as follows: 26,315 shares subject to the restricted stock unit award vested on the Transaction Date; 59,868 shares subject to the restricted stock unit award will vest on February 15, 2023; 59,869 shares subject to the restricted stock unit award will vest on February 15, 2024; and 51,974 shares subject to the restricted stock unit award will vest on each of February 15, 2025 and February 15, 2026. (F3) Includes 223,685 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
2	Common	Common Stock	2022-01-04	F	D	7,613	$19.18	242,387	D	—	—	(F4) Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on the Transaction Date.